We studied 40 
An infusion of propofol supplemented with an infusion of a short-acting opioid analgesic has been shown to provide satisfactory anaesthesia for a variety of surgical procedures [1, 2] . Alfentanil has been used widely as an analgesic administered as a bolus or infusion during general anaesthesia [3] .
Pharmaceutical studies have shown that mixing of propofol 10 mg ml" 1 (Diprivan, ICI) with alfentanil 500 ug ml" 1 (Rapifen, Janssen Pharmaceutical) in a ratio of 20:1 to 50:1, vol/vol, does not affect the stability of the emulsion or the amount of each constituent in the mixture over a 6-h period [ICI pharmaceutical mixing study, data on file]. We investigated the pharmacodynamic stability of a mixture of these drugs in a double-blind study to determine if alfentanil was sequestered in the fatty emulsion of the propofol with an associated delay or decrease in its effect.
approval was obtained and written informed consent was obtained from all patients. Premedication consisted of temazepam 20-40 mg orally. Patients were allocated randomly to receive either separate infusions of propofol and alfentanil, or a mixed infusion of propofol and alfentanil. Induction of anaesthesia was achieved in both groups with bolus doses of alfentanil 250 ug and propofol 1 mg kg" 1 with additional propofol 20-30 mg, if necessary. The infusions of propofol and alfentanil were begun simultaneously with the administration of the induction boluses. When anaesthesia was established, as judged by loss of eyelash reflex and absence of purposeful movement, suxamethonium 1 mg kg" 1 was administered, the vocal cords were sprayed with 5 % lignocaine and the trachea was intubated with a cuffed tracheal tube. Spontaneous ventilation was allowed to resume, breathing 33 % oxygen in nitrous oxide via a Bain circuit. Syringes were prepared in advance by a separate anaesthetist so that the study was blind to the investigator. The syringes were prepared as follows: group 1: a 50-ml syringe containing a mixture of alfentanil 1 mg in 2 ml and propofol 40 ml and a second syringe containing 5 % glucose 42 ml; group 2: a 50-ml syringe containing propofol 40 ml with 5 % glucose 2 ml and a second syringe containing alfentanil 1 mg in 2 ml with 5 % glucose 40 ml.
The infusions were delivered by Braun Perfusor Secura double syringe driver which administers the contents of two syringes at the same rate. The propofol infusion regimen was based on the method described by Roberts and colleagues [4] : 10 mg kg" 1 h" 1 for 10 min, 8 mg kg" 1 h" 1 for a further 10 min and a continuous infusion of 6 mg kg" 1 h" 1 thereafter. End-tidal carbon dioxide and ventilatory frequency were measured using a Hewlett-Packard 47210A capnometer and arterial pressure and heart rate were measured using a.Critikon 8100 Dinamap. The infusion rates were altered depending on the cardiorespiratory responses of the patient and their reaction to surgery. The infusion regimen was adhered to until surgery was started and altered
PATIENTS AND METHODS
We studied 40 adults (ages 16-70 yr, weights 46-97 kg) undergoing minor, elective, body surface surgery. Thirty-four of the patients were undergoing varicose vein surgery and the remainder excision/ biopsy of breast lumps. Local Ethics Committee thereafter if the criteria for apnoea were met (n = 22) or if the patient was inadequately anaesthetized (n = 1), as judged by movement after incision or excessive increases in heart rate, mean arterial pressure or ventilation frequency. Apnoea was denned as endtidal carbon dioxide ^ 8.6 kPa or ventilatory frequency ^ 4 b.p.m., maintained for 30 s or more. In those patients who became apnoeic, the infusion rate was reduced by increments of approximately 20 %, allowing 8-10 min for equilibration. If this was inadequate, the procedure was repeated until spontaneous ventilation and satisfactory cardiorespiratory variables were achieved. Patients' lungs were ventilated manually during any apnoeic periods. No patient required the infusion rate changes to be reversed later in the procedure. The final infusion rate at which cardiorespiratory variables were stable and acceptable was deemed to be the maintenance infusion rate.
The times from cessation of the maintenance infusion rate to obeying commands and to giving correct date of birth were noted. Analgesic requirements during the first 4 h after operation were assessed using a Graseby patient-controlled analgesia (PCA) system. A bolus dose of morphine 1 mg ml" 1 was available with a lockout time of 3 min. The information was stored on a data logger, a custom made device which communicated electronically with the PCA system. The data were retrieved and stored on a computer floppy disc at the end of the study period. Time to first demand and total morphine consumption during the first 4 h after recovery from anaesthesia were noted.
Statistical analysis was performed using the Mann-Whitney, chi-square and the Student's t tests where appropriate.
RESULTS
There were no significant differences between the groups in respect of patient characteristics (table I) or baseline measurements of end-tidal carbon dioxide, mean arterial pressure (MAP), heart rate and ventilatory frequency (table II) . Induction dose, total dose of propofol and duration of anaesthesia were similar in both groups (table III) . There were no differences between the two groups in minimum heart rate, minimum ventilatory frequency or maximum end-tidal carbon dioxide (table IV) . The maximum end-tidal carbon dioxide values were analysed only in those patients who maintained spontaneous ventilation with this infusion regimen. The power of the study with respect to the end-tidal carbon dioxide measurements was 0.89, taking 1 kPa as a relevant difference and a probability significance threshold of 0.05. There was no significant difference in MAP between the two groups at any time during the procedure ( fig. 1 ). The power of the study with respect to MAP measurements was 0.82, taking 10 mm Hg as a relevant difference and a significance threshold of 0.05.
The maintenance rate was reduced in 22 of the 40 patients studied because of apnoea but there was no difference in the frequency of apnoea between the two groups (table IV). The timing of the onset of apnoea was distributed throughout all three infusion rates and was not associated with lack of surgical stimulation. Only one patient required a greater maintenance rate than the regimen prescribed.
Times from cessation of infusion to giving correct date of birth were similar for both groups (table V) . The time from giving correct data of birth to first demand for analgesia from the PCA system was similar in both groups. There were no significant differences in the numbers of patients who required analgesia after surgery or in their requirement for morphine during the first 1 h and first 4 h after operation (table V) . DISCUSSION The degree of respiratory and cardiovascular depression between two groups has been used previously to demonstrate differences between i.v. opioid and non-opioid analgesics [5] . In the present study, we measured maximum end-tidal carbon dioxide, minimum ventilatory frequency, minimum mean arterial pressure, minimum heart rate and maintenance infusion requirements to determine if there was a difference between the two groups with regard to degree of respiratory or cardiovascular depression and hence the pharmacodynamic stability of the mixed infusion compared with the separate infusions. There was no difference between the two infusion regimens for any of the variables measured.
The use of PCA provided an unbiased assessment of the analgesic effect of alfentanil in the postoperative period. A similar number of patients required no analgesia within the first 4 h after operation. Of those who did require additional morphine, similar doses were administered by the two groups in the first 1 h and the first 4 h after operation. There was no difference between the two groups in the time from giving correct date of birth to first use of the PCA system. The similarity of the analgesic requirements and the recovery times showed that there was no delayed effect of alfentanil associated with the mixture. We conclude, therefore, that alfentanil may be administered as a mixture with propofol for maintenance of anaesthesia with no discernible reduction in analgesic potency.
The propofol infusion regimen [4] used in the present study was designed to produce a plasma concentration of propofol 3 ug ml" 1 , using a bolus dose to load the central compartment, and a threestage reducing infusion to compensate for redistribution and clearance. Computer predictions of plasma concentrations of alfentanil [6] which would result from the three-stage infusion regimen used in this study show that a central compartment concentration of 28-30 ng ml" 1 would be achieved during the two high flow stages of the infusion and would then increase steadily from 30 to 37 ng ml" 1 over the following 1 h at maintenance infusion rates.
The final infusion regimen used did not appear to be completely satisfactory as an anaesthetic regimen for this group of patients. The initial loading dose of propofol of 1 mg kg" 1 was found to be inadequate in most patients, with 27 of the total 40 patients requiring additional propofol to complete induction successfully. This increased the mean induction dose to 1.3 mg kg" 1 which would result in a predicted peak plasma concentration of approximately 5 ug ml" 1 compared with a predicted concentration of 4 ug ml" 1 which would be achieved with 1 mg kg" 1 . In a previous study, in which no alfentanil was given, a predicted plasma concentration of 4 ug ml" 1 failed to induce anaesthesia in 25 % of patients within 3 min whereas a target of 5 ug ml" 1 completed induction successfully in 90% of patients within this time [7] .
The maintenance rate was reduced in more than 50% of the patients studied because of apnoea. However, there was no difference in the frequency of apnoea between the two groups and the timing of the onset of apnoea was distributed evenly throughout the infusion rates and was not associated with lack of surgical stimulation.
Only one of 40 patients required a larger maintenance rate than the regimen prescribed, with the implication that this dose regimen is excessive for minor body surface surgery. This contrasts with the results reported by Tackley and colleagues [8] , who studied a mixed population undergoing hernia repair and varicose vein surgery, where two of eight patients anaesthetized with this propofol regimen required supplementation with a volatile anaesthetic agent. This may be attributed to patients undergoing hernia repair requiring deeper levels of anaesthesia than those required in the present study. Alternatively, the administration of morphine 0.15 mg kg" 1 as premedication and the sole analgesic agent may have resulted in a reduced level of intraoperative analgesia compared with our continuous infusion of alfentanil. This propofol infusion regimen, therefore, appears to lack the necessary flexibility in control to cope with the varying anaesthetic requirements of patients breathing spontaneously.
